RenovoRx - RNXT Company profit before taxes, interest and amortization

Brandmark of renovorx.com (RNXT)

Export control risks for high-tech software create a certain vulnerability for RenovoRx, Inc. (RNXT). The company's total operating profit on this chart demonstrates current liquidity, while 0.00 determines the current status of the parameter. Stable laboratory operations guarantee system scaling, and profitability is based on the implementation of targeted chemotherapy technologies for specialized hospitals and oncological surgeons.

RenovoRx, Inc. (RNXT) Profit before payment of interest, taxes and amortization: for the period 11/23/2025 - 11/14/2026

RenovoRx (RNXT) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Market Chart RenovoRx Corporation|RNXT - Consensus Target
- issuer market value details:
Market Value RenovoRx|RNXT - Total Company Value
- issuer book value statistics:
Net Asset Value per Share RenovoRx|RNXT - Company Book Value|Market Cap to Net Assets Ratio renovorx.com|RNXT - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital RenovoRx, Inc.|RNXT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio RenovoRx Inc|RNXT - Company Aggregate Debts|Debt to Net Assets Ratio RenovoRx|RNXT - Company Long-Term Debt|Company Short-Term Loans and Borrowings RenovoRx|Immediate Liquidity renovorx.com
- earnings and market multiples details:
RNXT - Company Net Income|Net Profit Forecast RenovoRx, Inc.|RNXT - Price to Earnings Ratio|Projected Price to Earnings Ratio renovorx.com|RNXT - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RenovoRx|RNXT - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months RenovoRx|RNXT - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months renovorx.com|RNXT - Net earnings per share growth this year|Projected earnings per share growth rate for next year RenovoRx, Inc.
- sales and revenue data:
RNXT - Company Sales|Company Future Revenue RenovoRx Corporation|RNXT - P/S Multiple|Market Cap to Expected Sales Ratio RenovoRx
Summary company analytics:RenovoRx Corporation
Original product of RenovoRx Corp

This indicator measures daily operating cash flow, excluding the impact of the tax burden and debt service costs to assess the real efficiency of the business. Analyzing the EBITDA history allows an investor to correlate returns with volatility, which is critical for RenovoRx, Inc. (RNXT), as the development costs for the RenovoTAMP platform determine the company's financial stability during the clinical trial phase.

Competitors of RenovoRx, Inc. (RNXT)

Operating income before deduction of amortization TriSalus Corp (TLSI)|PMCB: Operating profit before deduction of amortization